Atlas Trials

To Evaluate Efficacy and Safety of TopicalKX-826 Solution in Chinese Male Patients With Androgenetic Alopecia

Clinical trial NCT06622824 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06622824
Sponsor
Suzhou Kintor Pharmaceutical Inc,
Status
NOT_YET_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Androgenetic Alopecia (AGA)
Start date
2024-10-15
Primary completion
2027-10-20
Enrollment
756

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.